×
Join Our Mailing List
Preliminary Agenda Released. Special Early Bird Savings End August 22REGISTER NOW
View 2025 Video Highlights
Testimonials
2025 Gallery Highlights

Celebrate 25 Years
of Innovation at PepTalk

Join a vibrant community of scientists, trailblazers, and industry leaders at PepTalk 2026, as we mark 25 years of accelerating breakthroughs in biotherapeutic discovery and development. Renowned as one of the most influential events in protein science, PepTalk is where fresh ideas ignite, collaborations flourish, and next-generation solutions take shape.

This year’s expanded agenda features symposia and conference tracks, covering protein expression, production platforms, lab automation for higher throughput, analytical characterization and preformulation strategies for novel modalities, antibody discovery and development, and new this year - expression and development of therapeutic peptides and miniproteins.

Gain insights from expert speakers, engage with a dedicated community, and leave with tools and strategies to move your research forward.

Experience four days of focused learning, expert-led sessions, poster presentations, keynotes, roundtables, panel discussions, exhibitions, and networking opportunities.

200 Presentations
200 Presentations
100 Posters
1000 Participants
75 Exhibitors

Plenary Fireside Chat: Trends and Innovation Driving the Future of Biotherapeutics


John K. Kawooya, PhD

MODERATOR:
John K. Kawooya, PhD, Private Consultant, Robotics-Plate-Based-Ultra-HT Biologics Purification

Lieza Danan, PhD

PANELISTS:
Lieza Danan, PhD, Founder & CEO, LiVeritas

Yves Fomekong Nanfack, PhD

Yves Fomekong Nanfack, PhD, Executive Director & Head, End-to-End AI Foundations, Large Molecules Research Platform, Sanofi

Aline de Almeida Oliveira, PhD

Aline de Almeida Oliveira, PhD, Competitive Intelligence Advisor (AICOM), Board of Directors, Bio-Manguinhos/Fiocruz, Brazil


The PepTalk Legacy Panel : 25 Years of Science, and the Next Era of Protein Research

Ian Hunt

Moderator:
Ian Hunt
Global Head of Scientific Engagement Strategy, Novartis Pharma AG

Nicola Burgess-Brown, PhD

Panelists:
Nicola Burgess-Brown, PhD
Professorial Research Fellow, UCL, London; COO, Protein Sciences, Structural Genomics Consortium

Henry C. Chiou, PhD

Henry C. Chiou, PhD
Senior Director General Manager, Biosciences, Thermo Fisher Scientific (Retired)

Dominic Esposito, PhD

Dominic Esposito, PhD
Director, Protein Sciences, Frederick National Laboratory for Cancer Research

Deborah Moore-Lai, PhD

Deborah Moore-Lai, PhD
Vice President, Protein Sciences, ProFound Therapeutics

David W. Wood, PhD

David W. Wood, PhD
Professor, Chemical & Biomolecular Engineering, The Ohio State University